Review
Accepted on 02 Dec 2024
Anticoagulation Approach in Morbid Obesity: A Comprehensive Review on Venous Thromboembolism Management
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1457280
Type at least 3 characters
1,210 articles
Articles
Case Report
Accepted on 29 Nov 2024
Antithrombotic therapy for a patient of acute myocardial infarction after laparoscopic radical cystectomy
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477715
Original Research
Published on 29 Nov 2024
O304 alleviates abdominal aortic aneurysm formation via AMPK/mTOR/MMP pathway activation
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1457817
- 341 views
Correction
Accepted on 27 Nov 2024
Corrigendum: (Pro)renin receptor aggravates myocardial pyroptosis in diabetic cardiomyopathy through AMPK-NLRP3 pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1532331
Original Research
Published on 27 Nov 2024
Empagliflozin improves pressure-overload-induced cardiac hypertrophy by inhibiting the canonical Wnt/β-catenin signaling pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499542
- 195 views
Original Research
Accepted on 26 Nov 2024
Comparative Analysis of Mineralocorticoid Receptor Antagonists and Renin-Angiotensin System Inhibitors/Angiotensin Receptor Neprilysin Inhibitor in Heart Failure with Mildly Reduced Ejection Fraction
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1507326
Original Research
Published on 26 Nov 2024
Kinetics of endothelin-1 and effect selective ETA antagonism on ETB activation: a mathematical modeling analysis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1332388
- 132 views
Editorial
Accepted on 25 Nov 2024
'Editorial: Cytochromes P450, Their Modulators and Metabolites in Cardiovascular Function and Disease'
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1531166
Original Research
Published on 25 Nov 2024
Diagnostic and prognostic values of HCG15 and morrbid in acute myocardial infarction
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1492746
- 123 views
Original Research
Published on 25 Nov 2024
Transglutaminase 2 regulates endothelial cell calcification via IL-6-mediated autophagy
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393534
- 125 views
Original Research
Published on 21 Nov 2024
Endothelium-derived 6-nitrodopamine is the major mechanism by which nitric oxide relaxes the rabbit isolated aorta
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1507802
- 174 views
Original Research
Published on 20 Nov 2024
Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1467132
- 260 views
Review
Published on 19 Nov 2024
Epidemiology, clinical characteristics and potential mechanism of ibrutinib-induced ventricular arrhythmias
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1513913
- 188 views
Original Research
Accepted on 18 Nov 2024
Post-Conditioning on Myocardial Ischemia-Reperfusion Injury
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1470142
Original Research
Published on 18 Nov 2024
Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1453989
- 171 views
Review
Published on 18 Nov 2024
Amentoflavone for treating cardiocerebrovascular diseases and neurological disorders
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1406510
- 137 views